title: Bortezomib, melphalan, and prednisone in elderly relapsed/refractory multiple myeloma patients: update of multicenter, open-label Phase 1/2 study.
authors.affiliation: a Hematology Service, Department of Cellular Biotechnology and Hematology , ' Sapienza' University , Rome , Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Grammatico
authors.affiliation: b Department of Hematology , University of Torino , Turin , Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Bringhen
authors.affiliation: a Hematology Service, Department of Cellular Biotechnology and Hematology , ' Sapienza' University , Rome , Italy.
authors.forename: Federico
authors.initials: F
authors.lastname: Vozella
authors.affiliation: c Department of Hematology , S. Eugenio Hospital , Rome , Italy.
authors.forename: Agostina
authors.initials: A
authors.lastname: Siniscalchi
authors.affiliation: b Department of Hematology , University of Torino , Turin , Italy.
authors.forename: Mario
authors.initials: M
authors.lastname: Boccadoro
authors.affiliation: a Hematology Service, Department of Cellular Biotechnology and Hematology , ' Sapienza' University , Rome , Italy.
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Petrucci
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D000069286:Bortezomib / Q000008:administration & dosage; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D011241:Prednisone / Q000008:administration & dosage; D012008:Recurrence; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000069286:Bortezomib; D008558:Melphalan; D011241:Prednisone